Valuation Jade Biosciences, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 11:44:35 2026-07-08 EDT			5-day change	1st Jan Change
22.11 ^USD	-1.51%		+1.65%	+43.68%

07-02	Jade Biosciences to Receive up to $22 Million as Part of Licensing Deal With Paragon Therapeutics	MT
06-29	Jade Biosciences, Inc.(NasdaqCM:JBIO) added to Russell Microcap Growth Benchmark Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027	2028
Market Cap ¹	709.8	1,333	-	-
Change	-	87.74%	-	-
Enterprise Value (EV) ¹	373.7	1,079	1,032	1,003
Change	-	188.77%	-4.33%	-2.86%
P/E	-4.84x	-8.63x	-8.71x	-8.75x
PBR	-	5.3x	10.1x	6.09x
PEG	-0.2x	0.5x	9.24x	18.24x
Capitalization / Revenue	-	-	-	-
EV / Revenue	-	-	-	-
EV / EBITDA	-	-5.69x	-5.26x	-4.94x
EV / EBIT	-3.29x	-5.99x	-5.27x	-4.54x
EV / FCF	-3.94x	-6.77x	-5.92x	-4.92x
FCF Yield	-25.4%	-14.8%	-16.9%	-20.3%
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-3.19	-2.601	-2.577	-2.564
Distribution rate	-	-	-	-
Net sales ¹	-	-	-	-
EBITDA ¹	-	-189.7	-196.2	-203
EBIT ¹	-113.5	-180.3	-196	-220.7
Net income ¹	-127.4	-173.2	-191.2	-218.4
Net Debt ¹	-336.2	-253.5	-300.3	-329.8
Reference price ²	15.43	22.45	22.45	22.45
Nbr of stocks (in thousands)	46,004	59,360	-	-
Announcement Date	3/6/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JADE BIOSCIENCES, INC.	-8.63x	-	-5.69x	-	1.33B
LONZA GROUP AG	34.53x	6.07x	18.77x	0.95%	49.74B
REVOLUTION MEDICINES, INC.	-23.85x	349.22x	-22.56x	-.--%	40.49B
BEONE MEDICINES AG	47.3x	4.68x	29.91x	-.--%	34.35B
IQVIA HOLDINGS INC.	25.34x	2.8x	12.11x	-.--%	34.75B
CELLTRION, INC.	27.63x	7.94x	19.87x	0.41%	26.98B
MEDPACE HOLDINGS, INC.	32.22x	5.2x	23.7x	-.--%	15.6B
IONIS PHARMACEUTICALS, INC.	-24.06x	15.69x	-23.46x	-.--%	14.27B
EUROFINS SCIENTIFIC SE	23.93x	2.04x	8.96x	1.12%	13.76B
Average	14.94x	49.20x	6.85x	0.31%	25.7B
Weighted average by Cap.	19.37x	66.31x	9.32x	0.32%